Cargando…

SAPHO Syndrome Complicated by Lesions of the Central Nervous System Successfully Treated with Brodalumab

Synovitis-acne-pustulosis-hyperostosis-osteitis (SAPHO) syndrome is a rare disease with an unknown entity that affects the skin and the peripheral and/or axial joints. Here, we report on a patient with SAPHO syndrome complicated by lesions of the central nervous system who was successfully treated w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Funabiki, Masahide, Tahara, Masayuki, Kondo, Seiko, Ayuzawa, Naho, Yanagida, Hidetoshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9935794/ https://www.ncbi.nlm.nih.gov/pubmed/36816450 http://dx.doi.org/10.1155/2023/6005531

Ejemplares similares

Eczematous eruption after brodalumab successfully treated with guselkumab and dupilumab
por: Megna, Matteo, et al.
Publicado: (2022)

SAPHO Syndrome Complicated by Ankylosing Spondylitis Successfully Treated With Tofacitinib: A Case Report
por: Yuan, Fangfang, et al.
Publicado: (2022)

Successful Treatment of SAPHO Syndrome Complicated with Ankylosing Spondylitis by Secukinumab: A Case Report
por: Tu, Wei, et al.
Publicado: (2023)

Brodalumab to the Rescue: Efficacy and Safety of Brodalumab in Patients with Psoriasis and Prior Exposure or Inadequate Response to Biologics
por: Menter, Alan, et al.
Publicado: (2020)

SAPHO Syndrome with Palmoplantar Pustulosis as the First Manifestation Successfully Treated with Adalimumab
por: Yang, Qingyun, et al.
Publicado: (2022)

A case of SAPHO syndrome with the lesions limited to the skull
por: Oguro, Eri, et al.
Publicado: (2020)

SAPHO syndrome can cause sausage finger lesions
por: Jiang, Haixu, et al.
Publicado: (2023)

Sapho : mceurs parisiennes
por: Daudet, Alphonse, 1840-1897

Successful treatment of hip involvement in SAPHO syndrome with baricitinib
por: , Wuriliga, et al.
Publicado: (2022)

Brodalumab in psoriasis: evidence to date and clinical potential
por: Foulkes, Amy C, et al.
Publicado: (2019)

Malignancy Rates in Brodalumab Clinical Studies for Psoriasis
por: Gottlieb, Alice, et al.
Publicado: (2020)

Rapid resolution of pyoderma gangrenosum with brodalumab therapy
por: Tee, Michael W., et al.
Publicado: (2020)

Brodalumab in the treatment of psoriatic arthritis – the latest reports
por: Banaszczyk, Katarzyna
Publicado: (2021)

Two-Year US Pharmacovigilance Report on Brodalumab
por: Lebwohl, Mark, et al.
Publicado: (2020)

Three‐year U.S. pharmacovigilance report of brodalumab
por: Lebwohl, Mark, et al.
Publicado: (2021)

Narrative Review of the Emerging Therapeutic Role of Brodalumab in Difficult-to-Treat Psoriasis
por: Menter, Alan, et al.
Publicado: (2022)

Severe Psoriasis Successfully Treated with Brodalumab after Eradication of Hepatitis C Virus with Glecaprevir and Pibrentasvir: A Case Report
por: Ito, Michiko, et al.
Publicado: (2021)

SAPHO syndrome: a review
por: Rukavina, Iva
Publicado: (2015)

Clinical potential of brodalumab in the management of psoriasis: the evidence to date
por: Sandoval, Laura F, et al.
Publicado: (2015)

Spotlight on brodalumab in the treatment of plaque psoriasis: the evidence to date
por: Galluzzo, M, et al.
Publicado: (2019)

Paradoxical psoriatic arthritis flare with the initiation of brodalumab and guselkumab
por: Kashlan, Reem, et al.
Publicado: (2021)

Case report: successful treatment of refractory SAPHO syndrome with the JAK inhibitor tofacitinib
por: Yang, Qiao, et al.
Publicado: (2018)

Chronic non-bacterial osteomyelitis in SAPHO syndrome complicated by subclavian vein obstruction
por: Leerling, Anne T, et al.
Publicado: (2023)

SAPHO Syndrome: An Unusual Cause of Dysphagia
por: Hoffer, Megan, et al.
Publicado: (2021)

Brodalumab for the Treatment of Psoriasis: A Review of Phase III Trials
por: Farahnik, Benjamin, et al.
Publicado: (2016)

Population pharmacokinetics of brodalumab in patients with moderate to severe plaque psoriasis
por: Timmermann, Stine, et al.
Publicado: (2019)

Protocol for the safety of brodalumab regarding psychiatric comorbidities in patients with psoriasis
por: Pikou, O., et al.
Publicado: (2022)

Effectiveness of Brodalumab in Patients with Moderate-to-Severe Plaque Psoriasis Located in Difficult-to-Treat Areas
por: Cacciapuoti, Sara, et al.
Publicado: (2023)

Brodalumab in the Treatment of Plaque Psoriasis Localized in Difficult-to-Treat Areas: A Narrative Review
por: Cannizzaro, Maria Vittoria, et al.
Publicado: (2023)

Brodalumab for the treatment of moderate-to-severe psoriasis: case series and literature review
por: Pinter, Andreas, et al.
Publicado: (2019)

Brodalumab for the Treatment of Moderate-to-Severe Psoriasis: An Expert Delphi Consensus Statement
por: Fargnoli, Maria Concetta, et al.
Publicado: (2023)

SAPHO Syndrome Masquerading as Metastatic Breast Cancer
por: Malik, Devin, et al.
Publicado: (2018)

Mandibular Osteitis Leading to the Diagnosis of SAPHO Syndrome
por: Kikuchi, Tomohiro, et al.
Publicado: (2018)

SAPHO syndrome: A radiological case report
por: Singh, Anil Kumar, et al.
Publicado: (2020)

Tonsillectomy as an effective treatment for arthralgia of SAPHO syndrome
por: Horiguchi, Sena, et al.
Publicado: (2020)

Transient hypercalcemia in a patient with SAPHO syndrome
por: Yoshida, Tadashi, et al.
Publicado: (2021)

SAPHO Syndrome Accompanied by Thoracic Outlet Syndrome
por: Okuno, Shushi, et al.
Publicado: (2022)

Effectiveness of Long-Term Treatment with Brodalumab on Anxiety or Depressive Symptoms in Japanese Patients with Psoriasis: The ProLOGUE Study
por: Ohata, Chika, et al.
Publicado: (2023)

Dermatology Life Quality Index in Patients with Moderate-to-Severe Plaque Psoriasis Treated with Brodalumab or Ustekinumab
por: Lambert, Jo, et al.
Publicado: (2021)

A Case of SAPHO Syndrome Complicated by Uveitis with Good Response to Both TNF Inhibitor and JAKinib
por: Baisya, Ritasman, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_a4r1c5uo64c2bs7birvsnr70dk